High risk of rectal cancer and of metachronous colorectal cancer in probands of families fulfilling the amsterdam criteria

Annals of Surgery

Volumn 257, Issue 5, 2013, Pages 900-904

  Cirillo, Laura ^a   Urso, Emanuele Dl ^b   Parrinello, Giovanni ^a   Pucciarelli, Salvatore ^b   Moneghini, Dario ^a   Agostini, Marco ^b   Nitti, Donato ^b   Nascimbeni, Riccardo ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Amsterdam criteria; colorectal surgery; familial colorectal cancer type X; Lynch syndrome; proband; rectal cancer

Indexed keywords

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EVALUATION; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DECISION MAKING; FEMALE; HUMAN; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECTUM CANCER; RETROSPECTIVE STUDY; TOTAL COLON RESECTION;

ADULT; COHORT STUDIES; COLECTOMY; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84876297318     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31826bff79     Document Type: Article

References (23)

1. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919-932.
2. Boland CR. Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer. 2005;4:211-218.
3. Lynch HT, Lynch PM. Clinical selection of candidates for mutational testing for cancer susceptibility. Oncology. 2006;20:29-34.
4. Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006;96:1507-1517.
5. Vasen HFA, Moeslein G, Alonso A, et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet. 2007;44:353-362.
6. Tranø G, Sjursen W, Wasmuth HH, et al. Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study. Br J Cancer. 2010;102:482-488.
7. Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005;293:1979-1985.
8. Mueller-Koch Y, Vogelsang H, Kopp R, et al. Hereditary nonpolyposis col-orectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut. 2005;54:1733-1740.
9. Church J. Prevention of metachronous colorectal cancer in patients with Lynch syndrome. Dis Colon Rectum. 2010;53:3-4.
10. Tranø G, Wasmuth HH, Sjursen W, et al. Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population-based study. Colorectal Dis. 2009;11:456-463.
11. Kalady MF, McGannon E, Vogel JD, et al. Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria. Ann Surg. 2010;252:507-511.
12. Vasen H, Watson P, Mecklin J-P, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology. 1999;116: 1453-1456.
13. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria; 2011.
14. Natarajan N, Watson P, Silva-Lopez E, et al. Comparison of extended colec-tomy and limited resection in patients with Lynch syndrome. Dis Colon Rectum. 2010;53:77-82.
15. Parry S, Win AK, Parry B, et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut. 2011;60:950-957.
16. Fitzgibbons RJ Jr, Lynch HT, Stanislav GV, et al. Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). Ann Surg. 1987;206:289-295.
17. Van Dalen R, Church J, McGannon E, et al. Patterns of surgery in patients belonging to Amsterdam-positive families. Dis Colon Rectum. 2003;46:617-620.
18. Rodriguez-Bigas MA, Vasen HFA, Mecklin JP, et al. Rectal cancer risk in hereditary non polyposis colorectal cancer after abdominal colectomy. Ann Surg. 1997;225:202-207.
19. Moeslein G, Nelson H, Thibodeau S, et al. Rectal carcinoma in HNPCC. Langenbecks Arch Chir. 1998;115:1467-1469.
20. Lee JS, Petrelli NJ, Rodriguez-Bigas MA. Rectal cancer in hereditary non-polyposis colorectal cancer. Am J Surg. 2001;181:207-210.
21. Vasen HF, Abdirahman M, Brohet R, et al. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroen-terology. 2010;138:2300-2306.
22. Zhang YZ, Sheng JQ, Li SR, et al. Clinical phenotype and prevalence of hereditary nonpolyposis colorectal cancer syndrome in Chinese population. World J Gastroenterol. 2005;11:1481-1488.
23. Hurlstone DP, Karajeh M, Cross SS, et al. The role of high-magnification-chromoscopic colonoscopy in hereditary nonpolyposis colorectal cancer screening. Am J Gastroenterol. 2005;100:2167-2173.